A prominent Democratic U.S. senator is slamming pharmaceutical companies for opposing marijuana legalization.

"To them it's competition for chronic pain, and that's outrageous because we don't have the crisis in people who take marijuana for chronic pain having overdose issues," Sen. Kirsten Gillibrand of New York said. "It's not the same thing. It's not as highly addictive as opioids are."

"On the federal level, we really need to say it is a legal drug you can access if you need it," she said.

Click here to read the complete article

Tom Angell ~ Forbes.com

Recent News Articles

Wednesday March 27

Can medicinal cannabis treat the tics in Tourette syndrome? - Cannabis News

in Medical News

by Bruce Kennedy - Editor in Chief

A pioneering clinical trial investigating medicinal cannabis as a potential treatment for people living with…

712 hits

Wednesday March 27

Ohio: Columbus’ first medical marijuana dispensary opens - Cannabis News

in Finance

by Bruce Kennedy - Editor in Chief

About 30 people waited in line Tuesday morning to shop in central Ohio’s first medical…

1863 hits

Wednesday March 27

CBD Expected to Have Explosive Growth In European Union - Cannabis News

in World News

by Bruce Kennedy - Editor in Chief

The market has been slower to grow than it has in the US. But that’s…

1783 hits

Wednesday March 27

4 Tips to Navigate the Hemp Gold Rush - Cannabis News

in Cannabis News

by Bruce Kennedy - Editor in Chief

Here’s what you need to know to protect your investment even as smart leaders work…

2145 hits

Thursday March 28

Pot & Real Estate: Port Hueneme's marijuana industry has commercial property values blazing - Cannabis…

in Real Estate

by Bruce Kennedy - Editor in Chief

Call it the “pot premium.” It’s driving up commercial real estate prices in the little…

1431 hits